Catalog Number:
CPTC-NANOG-3
Target Antigen:
Nanog Homeobox Peptide 3
Isotype:
IgG
Species:
Rabbit Monoclonal Antibody
Last Updated:
12/30/2020
Antigen Recognition(s):
Peptide, Recombinant Full-length
Thematic Panel(s):
Epithelial Mesenchymal Transition (EMT)
Result: Negative
Immuno-precipitation data obtained incubating CPTC-NANOG-3 and the recombinant NANOG (aa1-305, expected, MW ~31KDa)
Result: No Binding
Indirect ELISA using CPTC-NANOG-3 as primary antibody against recombinant NANOG protein (amino acids 1-305).
NCI Identification Number:
00263
Antigen Name:
Nanog Homeobox Peptide 3
CPTC Name:
CPTC-NANOG Peptide 3
Aliases:
Nanog Homeobox; Homeobox Transcription Factor Nanog; Homeobox Transcription Factor Nanog-Delta 48; Homeobox Protein NANOG; HNanog
Function:
The protein encoded by this gene is a DNA binding homeobox transcription factor involved in embryonic stem (ES) cell proliferation, renewal, and pluripotency. The encoded protein can block ES cell differentiation and can also autorepress its own expression in differentiating cells. Two transcript variants encoding different isoforms have been found for this gene.
NANOG (Nanog Homeobox) is a Protein Coding gene. Diseases associated with NANOG include Teratocarcinoma and Ovarian Serous Cystadenocarcinoma. Among its related pathways are Transcriptional Regulatory Network in Embryonic Stem Cell and Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. Gene Ontology (GO) annotations related to this gene include DNA binding transcription factor activity and chromatin binding. An important paralog of this gene is NANOGP8.
Transcription regulator involved in inner cell mass and embryonic stem (ES) cells proliferation and self-renewal. Imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. Blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes. Acts as a transcriptional activator or repressor. Binds optimally to the DNA consensus sequence 5-TAAT[GT][GT]-3 or 5-[CG][GA][CG]C[GC]ATTAN[GC]-3. Binds to the POU5F1/OCT4 promoter (PubMed:25825768). Able to autorepress its expression in differentiating (ES) cells: binds to its own promoter following interaction with ZNF281/ZFP281, leading to recruitment of the NuRD complex and subsequent repression of expression. When overexpressed, promotes cells to enter into S phase and proliferation.
Chromosomal Localization:
12p13.31
Accession Number:
NP_079141.2
UniProt Accession Number:
Q9H9S0
DNA Source:
The NCI acknowledges the generous advice and gene clones provided by Robert A. Weinberg at the Ludwig Center for Cancer Research of the Massachusetts Institute of Technology. These reagents have been provided by the Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Institute (NCI) using funding of the American Recovery and Reinvestment Act of 2009
Immunogen:
Synthetic Peptide
Vector Name:
N/A
Extinction Coefficient:
Buffers:
Expressed Sequence:
cFQPNSPASDLEAALEAAGEG
Native Sequence:
Calculated Isoelectric Point:
0
Molecular Weight:
2200
Last Updated:
09/16/2019
No SOPs available.
Get it for free at Adobe.com